InterCure Ltd. (NASDAQ:INCR) Short Interest Down 33.3% in February

InterCure Ltd. (NASDAQ:INCR) saw a large drop in short interest in February. As of February 15th, there was short interest totalling 27,400 shares, a drop of 33.3% from the January 31st total of 41,100 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily volume of 32,700 shares, the short-interest ratio is currently 0.8 days.

InterCure Stock Performance

Shares of NASDAQ:INCR traded down $0.05 during trading hours on Tuesday, hitting $1.57. 18,573 shares of the company’s stock traded hands, compared to its average volume of 42,288. InterCure has a 52 week low of $1.17 and a 52 week high of $3.72. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.15 and a current ratio of 1.78. The company’s fifty day simple moving average is $1.65 and its two-hundred day simple moving average is $1.69.

Hedge Funds Weigh In On InterCure

Several large investors have recently made changes to their positions in INCR. Jane Street Group LLC acquired a new stake in shares of InterCure during the 3rd quarter valued at $49,000. Virtu Financial LLC acquired a new stake in shares of InterCure during the 3rd quarter valued at $43,000. Finally, Moore Capital Management LP acquired a new stake in shares of InterCure during the 4th quarter valued at $156,000. Institutional investors own 8.34% of the company’s stock.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.